-
1
-
-
0141995781
-
Re: Doussis-Anagnostopoulou et al. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease
-
Agarwal B., and Naresh K.N. Re: Doussis-Anagnostopoulou et al. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease. J. Pathol. 201 (2003) 334-335
-
(2003)
J. Pathol.
, vol.201
, pp. 334-335
-
-
Agarwal, B.1
Naresh, K.N.2
-
2
-
-
23144455312
-
Matrix metalloproteinases participate in osteosarcoma invasion
-
Bjornland K., Flatmark K., Pettersen S., Aaasen A.O., Fodstad O., and Maelandsmo G.M. Matrix metalloproteinases participate in osteosarcoma invasion. J. Surg. Res. 127 (2005) 151-156
-
(2005)
J. Surg. Res.
, vol.127
, pp. 151-156
-
-
Bjornland, K.1
Flatmark, K.2
Pettersen, S.3
Aaasen, A.O.4
Fodstad, O.5
Maelandsmo, G.M.6
-
3
-
-
0034615550
-
Tissue inhibitors of metalloproteinases: evolution, structure and function
-
Brew K., Dinakarpandian D., and Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta 1477 (2000) 267-283
-
(2000)
Biochim. Biophys. Acta
, vol.1477
, pp. 267-283
-
-
Brew, K.1
Dinakarpandian, D.2
Nagase, H.3
-
4
-
-
0035500490
-
The many faces of metalloproteinases: cell growth, invasion, angiogenesis and metastasis
-
Chang C., and Werb Z. The many faces of metalloproteinases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol. 11 (2001) S37-S43
-
(2001)
Trends Cell Biol.
, vol.11
-
-
Chang, C.1
Werb, Z.2
-
5
-
-
0036057644
-
Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease
-
Doussis-Anagnostopoulou I.A., Talks K.L., Turley H., Debnam P., Tan D.C., Mariatos G., Gorgoulis V., Kittas C., and Gatter K.C. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease. J. Pathol. 197 (2002) 677-683
-
(2002)
J. Pathol.
, vol.197
, pp. 677-683
-
-
Doussis-Anagnostopoulou, I.A.1
Talks, K.L.2
Turley, H.3
Debnam, P.4
Tan, D.C.5
Mariatos, G.6
Gorgoulis, V.7
Kittas, C.8
Gatter, K.C.9
-
6
-
-
0030498734
-
Angiogenesis and metastasis
-
Ellis L.M., and Fidler L.J. Angiogenesis and metastasis. Eur. J. Cancer 32A (1996) 2413-2422
-
(1996)
Eur. J. Cancer
, vol.32 A
, pp. 2413-2422
-
-
Ellis, L.M.1
Fidler, L.J.2
-
7
-
-
0034200452
-
Expression of the matrix metalloproteinase 9 in Hodgkin's diasease is independent of EBV status
-
Flavell J.R., Baumforth K.R., Williams D.M., Lukesova M., Madarova J., Noskova V., Prochazkova J., Lowe D., Kolar Z., Murray P.G., and Nelson P.N. Expression of the matrix metalloproteinase 9 in Hodgkin's diasease is independent of EBV status. Mol. Pathol. 53 (2000) 145-149
-
(2000)
Mol. Pathol.
, vol.53
, pp. 145-149
-
-
Flavell, J.R.1
Baumforth, K.R.2
Williams, D.M.3
Lukesova, M.4
Madarova, J.5
Noskova, V.6
Prochazkova, J.7
Lowe, D.8
Kolar, Z.9
Murray, P.G.10
Nelson, P.N.11
-
8
-
-
0030764802
-
Expression of vascular endothelial growth factor in lymphomas and Castleman's disease
-
Foss H.D., Araujo I., Demel G., Klotzbach H., Hummel M., and Stein H. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. J. Pathol. 183 (1997) 44-50
-
(1997)
J. Pathol.
, vol.183
, pp. 44-50
-
-
Foss, H.D.1
Araujo, I.2
Demel, G.3
Klotzbach, H.4
Hummel, M.5
Stein, H.6
-
10
-
-
0038391043
-
Mechanisms and its regulation of tumor-induced angiogenesis
-
Gupta K.M., and Quin R.Y. Mechanisms and its regulation of tumor-induced angiogenesis. World J. Gastroenterol. 9 (2003) 1144-1155
-
(2003)
World J. Gastroenterol.
, vol.9
, pp. 1144-1155
-
-
Gupta, K.M.1
Quin, R.Y.2
-
11
-
-
0346655231
-
From the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesis
-
Harry L.E., and Paleolog E.M. From the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesis. Birth Defects Res. C Embryo Today 69 (2003) 363-374
-
(2003)
Birth Defects Res. C Embryo Today
, vol.69
, pp. 363-374
-
-
Harry, L.E.1
Paleolog, E.M.2
-
12
-
-
0036162169
-
Matrix metalloproteinase-9 and vascular endothelial growth factor: a possible link in adult T-cell leukaemia cell invasion
-
Hayashibara T., Yamada Y., Onimaru Y., Tsutsumi C., Nakayama S., Mori N., Miyanishi T., Kamihira S., Tomonaga M., and Maita T. Matrix metalloproteinase-9 and vascular endothelial growth factor: a possible link in adult T-cell leukaemia cell invasion. Br. J. Haematol. 116 (2002) 94-102
-
(2002)
Br. J. Haematol.
, vol.116
, pp. 94-102
-
-
Hayashibara, T.1
Yamada, Y.2
Onimaru, Y.3
Tsutsumi, C.4
Nakayama, S.5
Mori, N.6
Miyanishi, T.7
Kamihira, S.8
Tomonaga, M.9
Maita, T.10
-
13
-
-
0037294520
-
Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma
-
Ho C.L., Sheu L.F., and Li C.Y. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma. Ann. Diagn. Pathol. 7 (2003) 1-8
-
(2003)
Ann. Diagn. Pathol.
, vol.7
, pp. 1-8
-
-
Ho, C.L.1
Sheu, L.F.2
Li, C.Y.3
-
14
-
-
33746587879
-
Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer
-
Holten-Andersen M.N., Nielsen H.J., Sorensen S., Jensen V., Brunner N., and Christensen I.J. Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer. Eur. J. Cancer 42 (2006) 1889-1896
-
(2006)
Eur. J. Cancer
, vol.42
, pp. 1889-1896
-
-
Holten-Andersen, M.N.1
Nielsen, H.J.2
Sorensen, S.3
Jensen, V.4
Brunner, N.5
Christensen, I.J.6
-
15
-
-
35449001470
-
Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer
-
Iniesta P., Moran A., De Juan C., Gomez A., Hernando F., Garcia-Aranda C., Frias C., Diaz-Lopez A., Rodriguez-Jimenez F.J., Balibrea J.L., and Benito M. Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer. Oncol. Rep. 17 (2007) 217-223
-
(2007)
Oncol. Rep.
, vol.17
, pp. 217-223
-
-
Iniesta, P.1
Moran, A.2
De Juan, C.3
Gomez, A.4
Hernando, F.5
Garcia-Aranda, C.6
Frias, C.7
Diaz-Lopez, A.8
Rodriguez-Jimenez, F.J.9
Balibrea, J.L.10
Benito, M.11
-
17
-
-
0027300274
-
Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas
-
Kossakowska A.E., Urbanski S.J., Watson A., Hayden L.J., and Edwards D.R. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol. Res. 5 (1993) 19-28
-
(1993)
Oncol. Res.
, vol.5
, pp. 19-28
-
-
Kossakowska, A.E.1
Urbanski, S.J.2
Watson, A.3
Hayden, L.J.4
Edwards, D.R.5
-
18
-
-
0034485309
-
Matrix metalloproteinases and their tissue inhibitors-expression, role and regulation in human malignant non-Hodgkin's lymphomas
-
Kossakowska A.E., Urbanski S.J., and Janowska-Wieczorek A. Matrix metalloproteinases and their tissue inhibitors-expression, role and regulation in human malignant non-Hodgkin's lymphomas. Leukemia Lymphoma 39 (2000) 485-493
-
(2000)
Leukemia Lymphoma
, vol.39
, pp. 485-493
-
-
Kossakowska, A.E.1
Urbanski, S.J.2
Janowska-Wieczorek, A.3
-
19
-
-
18744383031
-
Diverse role of MMP-2 and MMP-9 in the clinicopathological behavior of Hodgkin's lymphoma
-
Kuittinen O., Soini Y., and Turpeenniemi-Huajen T. Diverse role of MMP-2 and MMP-9 in the clinicopathological behavior of Hodgkin's lymphoma. Eur. J. Haematol. 69 (2002) 205-212
-
(2002)
Eur. J. Haematol.
, vol.69
, pp. 205-212
-
-
Kuittinen, O.1
Soini, Y.2
Turpeenniemi-Huajen, T.3
-
20
-
-
30644476010
-
Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PDEGF) in classical Hodgkin lymphoma (HL)
-
Mainou-Fowler T., Angus B., Miller S., Proctor S.J., Taylor P.R., and Wood K.M. Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PDEGF) in classical Hodgkin lymphoma (HL). Leukemia Lymphoma 47 (2006) 223-230
-
(2006)
Leukemia Lymphoma
, vol.47
, pp. 223-230
-
-
Mainou-Fowler, T.1
Angus, B.2
Miller, S.3
Proctor, S.J.4
Taylor, P.R.5
Wood, K.M.6
-
22
-
-
0038118504
-
Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?
-
Moon W.S., Rhyu K.H., Kang M.J., Lee D.G., Yu H.C., Yeum J.H., Koh G.Y., and Tarnawski A.S. Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?. Mod. Pathol. 16 (2003) 552-557
-
(2003)
Mod. Pathol.
, vol.16
, pp. 552-557
-
-
Moon, W.S.1
Rhyu, K.H.2
Kang, M.J.3
Lee, D.G.4
Yu, H.C.5
Yeum, J.H.6
Koh, G.Y.7
Tarnawski, A.S.8
-
23
-
-
0036095975
-
Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells
-
Oelmann E., Herbst H., Zuhlsdorf M., Albrecht O., Nolte A., Schmitmann C., Manzke O., Diehl V., Stein H., and Berdel W.E. Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells. Blood 99 (2002) 258-267
-
(2002)
Blood
, vol.99
, pp. 258-267
-
-
Oelmann, E.1
Herbst, H.2
Zuhlsdorf, M.3
Albrecht, O.4
Nolte, A.5
Schmitmann, C.6
Manzke, O.7
Diehl, V.8
Stein, H.9
Berdel, W.E.10
-
24
-
-
0036095975
-
Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells
-
Oelmann E., Oelmann E., Herbst H., Zühlsdorf M., Albrecht O., Nolte A., Schmitmann C., Manzke O., Diehl V., Stein H., and Berdel W.E. Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells. Blood 99 (2002) 258-267
-
(2002)
Blood
, vol.99
, pp. 258-267
-
-
Oelmann, E.1
Oelmann, E.2
Herbst, H.3
Zühlsdorf, M.4
Albrecht, O.5
Nolte, A.6
Schmitmann, C.7
Manzke, O.8
Diehl, V.9
Stein, H.10
Berdel, W.E.11
-
26
-
-
0742269390
-
Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma
-
Potti A., Ganti A.K., Tendulkar K., Sholes K., Chitajallu S., Koch M., and Kargas S. Determination of vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas and the role of overexpression in leiomyosarcoma. J. Cancer Res. Clin. Oncol. 130 (2004) 52-56
-
(2004)
J. Cancer Res. Clin. Oncol.
, vol.130
, pp. 52-56
-
-
Potti, A.1
Ganti, A.K.2
Tendulkar, K.3
Sholes, K.4
Chitajallu, S.5
Koch, M.6
Kargas, S.7
-
27
-
-
24044459285
-
Matrix metalloproteinases and angiogenesis
-
Rundhaug J.E. Matrix metalloproteinases and angiogenesis. J. Cell Mol. Med. 9 (2005) 267-285
-
(2005)
J. Cell Mol. Med.
, vol.9
, pp. 267-285
-
-
Rundhaug, J.E.1
-
28
-
-
18244390735
-
Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein
-
Ruokolainen H., Paakko P., and Turpeenniemi-Hujanen T. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein. Clin. Cancer Res. 11 (2005) 3257-3264
-
(2005)
Clin. Cancer Res.
, vol.11
, pp. 3257-3264
-
-
Ruokolainen, H.1
Paakko, P.2
Turpeenniemi-Hujanen, T.3
-
29
-
-
9144242962
-
Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma
-
Sakata K., Satoh M., Someya M., Asanuma H., Nagakura H., Oouchi A., Nakata K., Kogawa K., Koito K., Hareyama M., and Himi T. Expression of matrix metalloproteinase 9 is a prognostic factor in patients with non-Hodgkin lymphoma. Cancer 100 (2004) 356-365
-
(2004)
Cancer
, vol.100
, pp. 356-365
-
-
Sakata, K.1
Satoh, M.2
Someya, M.3
Asanuma, H.4
Nagakura, H.5
Oouchi, A.6
Nakata, K.7
Kogawa, K.8
Koito, K.9
Hareyama, M.10
Himi, T.11
-
30
-
-
0030829035
-
Enhanced expression of endothelial growth factor in metastatic melanoma
-
Salven P., Heikkita P., and Joensuu H. Enhanced expression of endothelial growth factor in metastatic melanoma. Br. J. Cancer 76 (1997) 930-934
-
(1997)
Br. J. Cancer
, vol.76
, pp. 930-934
-
-
Salven, P.1
Heikkita, P.2
Joensuu, H.3
-
31
-
-
0034892043
-
Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer
-
Schmalfeldt B., Prechtel D., Harting K., Spathe K., Rutke S., Konik E., Fridman R., Berger U., Schmitt M., Kuhn W., and Lengyel E. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin. Cancer Res. 7 (2001) 2396-2404
-
(2001)
Clin. Cancer Res.
, vol.7
, pp. 2396-2404
-
-
Schmalfeldt, B.1
Prechtel, D.2
Harting, K.3
Spathe, K.4
Rutke, S.5
Konik, E.6
Fridman, R.7
Berger, U.8
Schmitt, M.9
Kuhn, W.10
Lengyel, E.11
-
32
-
-
1842415455
-
Vessel counts and expression of vascular endothelial growth factor as prognostic factor in node-negative colon cancer
-
Takahashi Y., Tucker S.L., Kitadai Y., Koura A.N., Bucana C.D., Cleary K.R., and Ellis L.M. Vessel counts and expression of vascular endothelial growth factor as prognostic factor in node-negative colon cancer. Arch. Surg. 132 (1997) 541-546
-
(1997)
Arch. Surg.
, vol.132
, pp. 541-546
-
-
Takahashi, Y.1
Tucker, S.L.2
Kitadai, Y.3
Koura, A.N.4
Bucana, C.D.5
Cleary, K.R.6
Ellis, L.M.7
-
33
-
-
0032530876
-
Matrix metalloproteinase-2 immunoreactive protein a marker of aggressiveness in breast carcinoma
-
Talvensaari-Matilla A., Paakko P., Hoyhtya M., Blanco-Sequeiros G., and Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 immunoreactive protein a marker of aggressiveness in breast carcinoma. Cancer 83 (1998) 1153-1162
-
(1998)
Cancer
, vol.83
, pp. 1153-1162
-
-
Talvensaari-Matilla, A.1
Paakko, P.2
Hoyhtya, M.3
Blanco-Sequeiros, G.4
Turpeenniemi-Hujanen, T.5
-
34
-
-
15244348390
-
Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers
-
Turpeenniemi-Hujanen T. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie 87 (2005) 287-297
-
(2005)
Biochimie
, vol.87
, pp. 287-297
-
-
Turpeenniemi-Hujanen, T.1
-
35
-
-
0031982331
-
In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis
-
Uchida S., Shimada Y., Watanabe G., Tanaka H., Shibagaki I., Miyahara T., Ishigami S., and Imamura M. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. Br. J. Cancer 77 (1998) 1704-1709
-
(1998)
Br. J. Cancer
, vol.77
, pp. 1704-1709
-
-
Uchida, S.1
Shimada, Y.2
Watanabe, G.3
Tanaka, H.4
Shibagaki, I.5
Miyahara, T.6
Ishigami, S.7
Imamura, M.8
-
36
-
-
0031431550
-
Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9
-
Vacca A., Moretti S., Ribatti D., Pellegrino A., Pimpinelli N., Bianchi B., Bonifazi E., Ria R., Serio G., and Dammacco F. Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. Eur. J. Cancer 33 (1997) 1685-1692
-
(1997)
Eur. J. Cancer
, vol.33
, pp. 1685-1692
-
-
Vacca, A.1
Moretti, S.2
Ribatti, D.3
Pellegrino, A.4
Pimpinelli, N.5
Bianchi, B.6
Bonifazi, E.7
Ria, R.8
Serio, G.9
Dammacco, F.10
-
37
-
-
0033134764
-
Bone marrow neovascularization, plasma cell angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma
-
Vacca A., Ribatti D., Presta M., Minischetti M., Iurlaro M., and Ria R. Bone marrow neovascularization, plasma cell angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 9 (1999) 3064-3073
-
(1999)
Blood
, vol.9
, pp. 3064-3073
-
-
Vacca, A.1
Ribatti, D.2
Presta, M.3
Minischetti, M.4
Iurlaro, M.5
Ria, R.6
|